Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort descending
Jul
9
2013
Energy and Environmental Law Update - Week of July 8, 2013 Mintz
Sep
9
2021
Federal Circuit Reiterates Requirement under § 287 that Alleged Infringers have Notice of Specific Alleged Infringement Mintz
Jul
24
2018
Significant Drug Pricing Developments in July – Here’s What You Need To Know Mintz
Oct
3
2013
What the Strong Initial Public Offering (IPO) Market Means for Emerging Energy and Renewable Technology Companies Mintz
Aug
15
2018
CMS Seeks to Lower Costs and Increase Competition with Step Therapy for Medicare Part B Drugs Mintz
Oct
8
2013
Energy and Environmental Law Update - Week of October 7, 2013 Mintz
Nov
16
2021
The End Is (Somewhat) Nigh: FDA Begins Rolling Back Enforcement Policies Implemented in Response to the COVID-19 Pandemic Mintz
Nov
15
2013
Innovative Exit Strategies in Life Sciences [VIDEO] Mintz
Oct
15
2018
ML Strategies Health Care Preview Week of October 15 Mintz
Dec
22
2013
Unified Patent System Will Save European Energy and Cleantech Innovators Thousands Mintz
Jan
21
2022
Written Description Requirement Challenges: Federal Circuit Decision Sheds Light on How Expert Testimony Can Help Mintz
Jun
3
2014
Health Care Law Update - June 2, 2014 Mintz
Feb
1
2019
HHS Proposes to Remove Drug Rebate Protections Mintz
Jun
10
2014
Energy & Environmental Law Update - June 9, 2014 Mintz
Jun
20
2014
Milk Processors Soured After Federal District Court Rules They Must Face Monopsonization Claims at Trial Mintz
Jul
1
2014
Energy & Environmental Law Update - June 30, 2014 Mintz
Aug
18
2014
The Food Fight Continues: Vermont AG Seeks to Dismiss Lawsuit Against GMO Labeling Law Mintz
Aug
26
2014
Health Care Law Update - August 25, 2014 Mintz
May
31
2022
Potential Pitfalls of Telehealth Prescribing Mintz
Oct
7
2014
Health Care Law Update - October 6, 2014 Mintz
Nov
25
2014
Energy and Environment Law Update: Week of 11/24/2014 Mintz
Jul
9
2019
Federal Judge Strikes Down HHS Drug Pricing Disclosure Rule Mintz
Apr
14
2015
Health Care Update for April 14, 2015 Mintz
Aug
8
2019
In Policy Reversal, HHS and FDA Propose Plan to Import Foreign Drugs Mintz
Jul
10
2015
Final Drug Shortage Reporting Rules Will Go Into Effect September 2015 Mintz
Jul
22
2015
FDA Issues Warning Letter to Corporate Sponsor of Clinical Trial Mintz
Sep
30
2019
HHS Files Brief in D.C. Circuit Supporting Drug Pricing Transparency Rule Mintz
Aug
30
2015
Another FTC Conduct Case to Bolster Generic Drug Competition: Pharmaceuticals Charged with Illegal Non-Compete for Generic ADHD Drug Sales Mintz
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins